Growth Hormone for Normal Short Children - Correction

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1184

June 7, 2004

View Complete Issue Table of Contents 2019

Growth Hormone for Normal Short Children - Correction

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2004 Jun 7;46(1184):46-8

Disclosures

Objective(s)

SUMMARY: Correction: Cost of Genotropin: A reader has pointed out that The Medical Letter article on Growth Hormone for Normal Short Children (Medical Letter 2003, volume 45, page 89) underestimated the annual cost of Genotropin (Pfizer) because the Genotropin Pen 5 Delivery Device that is used with 5.8-mg cartridges is designed to deliver 5.0 mg of the drug. The annual cost of Genotropin in our November 10, 2003 article should have been $22,625.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.